शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSERajnish Wellness Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 14 Nov, 2025 · 16:38 IST

Outcome of Board Meeting held today i.e. Friday, November, 2025

Revenue declinedNegative operating cash flowRelated-party transactionsResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹0.80
prior close
₹0.80
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-0.6% vs market
Pharmaceuticals peers, median of 157sector+0.1%-0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+1.3
30m
+1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.6-0.6+0.1-0.1
Next day
-1.3-0.2-1.0-0.7-0.6
2d
-3.8-0.4-3.4-1.1-2.7
3d
-5.0-0.7-4.3-0.9-4.1
4d
+3.8-2.2+6.0-2.0+5.7
5d
+7.5-2.8+10.3-3.2+10.7
1w
+0.0-1.4+1.4-2.2+2.2
15d
-16.3-7.0-9.2-4.7-11.5
1m
-20.0-6.1-13.9-5.0-15.0
2m
-37.5-9.2-28.3-7.6-29.9
3m
-42.5-6.8-35.7-9.5-33.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rajnish Wellness Ltd's board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). Revenue from operations for H1 FY26 fell sharply to ₹1,656.04 lakhs from ₹3,372.22 lakhs in H1 FY25, a drop of about 51% year-on-year. Profit after tax also declined to ₹27.98 lakhs from ₹44.45 lakhs. The company raised ₹2.47 crores through a Rights Issue but utilized only about ₹83.80 lakhs (entirely towards general corporate purposes), with no spending yet on the acquisition of Milan Trading Co or working capital augmentation. Operating cash flow turned deeply negative at -₹2,394.32 lakhs for H1 FY26, compared to a marginal positive ₹4.41 lakhs a year ago, mainly due to sharp jumps in trade receivables, inventories, and investments.

Likely market impact

The steep revenue decline and negative operating cash flow are worrying signs for shareholders, though the recent Rights Issue and zero-debt position provide some short-term liquidity cushion. Margin compression and weak fund utilization suggest the company is struggling to deploy capital into growth, which could weigh on the stock in the near term.